Swami U - Search Results

1

Impact of androgen receptor alterations on cell-free DNA genomic profiling on survival outcomes in metastatic castration-resistant prostate cancer.

Tripathi N, Thomas VM, Sayegh N, Gebrael G, Chigarira B, Jo Y, Li H, Sahu KK, Nussenzveig R, Nordblad B, Swami U, Agarwal N, Maughan BL. Tripathi N, et al. Among authors: swami u. Prostate. 2023 Dec;83(16):1602-1609. doi: 10.1002/pros.24618. Epub 2023 Aug 29. Prostate. 2023. PMID: 37644774

2

Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010.

Hou JY, Aparo S, Ghalib M, Chaudhary I, Shah U, Swami U, Einstein M, Goldberg GL, Mani S, Goel S. Hou JY, et al. Among authors: swami u. Gynecol Oncol. 2013 Oct;131(1):163-8. doi: 10.1016/j.ygyno.2013.07.089. Epub 2013 Jul 19. Gynecol Oncol. 2013. PMID: 23877015 Clinical Trial.

3

Immunotherapy and fatigue: what we know and what we don't know.

Azeem Khan M, Florou V, Swami U. Azeem Khan M, et al. Among authors: swami u. Oncotarget. 2021 Apr 13;12(8):719-720. doi: 10.18632/oncotarget.27946. eCollection 2021 Apr 13. Oncotarget. 2021. PMID: 33889294 Free PMC article. No abstract available.

4

Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.

Swami U, Goel S, Mani S. Swami U, et al. Curr Drug Targets. 2013 Jun;14(7):777-97. doi: 10.2174/1389450111314070007. Curr Drug Targets. 2013. PMID: 23597015 Free PMC article. Review.

5

Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active Melanoma.

Swami U, Swick B, Zakharia Y, Milhem M. Swami U, et al. Case Rep Oncol Med. 2019 Mar 7;2019:4683531. doi: 10.1155/2019/4683531. eCollection 2019. Case Rep Oncol Med. 2019. PMID: 30963012 Free PMC article.

6

Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti-PD-L1 Immunotherapy Be Administered after Anti-PD-1-Related Immune Toxicities?

Swami U, Lenert P, Furqan M, Abu Hejleh T, Clamon G, Zhang J. Swami U, et al. J Thorac Oncol. 2018 Jun;13(6):e102-e103. doi: 10.1016/j.jtho.2018.01.027. J Thorac Oncol. 2018. PMID: 29793647 Free article. No abstract available.

7

Gastrointestinal stromal tumors-are we stuck and the way forward.

Swami U, Monga V, Milhem M. Swami U, et al. Transl Gastroenterol Hepatol. 2017 Nov 20;2:93. doi: 10.21037/tgh.2017.11.07. eCollection 2017. Transl Gastroenterol Hepatol. 2017. PMID: 29264431 Free PMC article. No abstract available.

8

Eribulin -- a review of preclinical and clinical studies.

Swami U, Chaudhary I, Ghalib MH, Goel S. Swami U, et al. Crit Rev Oncol Hematol. 2012 Feb;81(2):163-84. doi: 10.1016/j.critrevonc.2011.03.002. Epub 2011 Apr 14. Crit Rev Oncol Hematol. 2012. PMID: 21493087 Free PMC article. Review.

9

Response to Erlotinib in a Patient with Compound EGFR L747S and Exon 19 Deletion.

Swami U, Ma D, Zhang J. Swami U, et al. J Thorac Oncol. 2018 Jul;13(7):e129-e130. doi: 10.1016/j.jtho.2018.03.034. J Thorac Oncol. 2018. PMID: 29935854 Free article. No abstract available.

10

Experience with vena cava filters at a large community hospital and level-I trauma center: indications, complications, and compliance barriers.

Swami U, Annunziata G, Fulger I. Swami U, et al. Clin Appl Thromb Hemost. 2014 Jul;20(5):546-52. doi: 10.1177/1076029613505766. Epub 2013 Oct 1. Clin Appl Thromb Hemost. 2014. PMID: 24085746 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters